Sequential Air Pressotherapy System with Far Infrared Warm Compression Therapy

Name: Sequential Air Pressotherapy System with Far Infrared Warm Compression Therapy
Brand: Guangzhou T&B Beauty Equipment Co., Ltd.
SKU: 2304929535

Guangdong, ChinaGuangzhou T&B Beauty Equipment Co., Ltd.

US$899.00

1-9 Pieces

US$799.00

10-99 Pieces

US$500.00

100+ Pieces

Sample price:US$899.00/piece.Request sample

Product profile

Customization

Available

Type

Rehabilitation

Function

Improve Blood Circulation

Model NO.

AP04B

Theory

Pressotherapy

Certification

CE, FDA, ISO13485

LCD Display

With LCD Display

Group

Adult

Main Function

Lymphatic Drainage ,Weight Loss

Trademark

TOP BEAUTY

Origin

China

Production Capacity

5000

Key features

Overlapping 24 airbags distribute force more evenly.

Combining pressure therapy and infrared radiation results in better treatment outcomes and higher efficiency.

Six treatment modes, easy to operate.

Includes an eye massager for a refreshing and stress-relieving effect.

Silent and rapid air exchange system: Provides fast and quiet air circulation, reducing treatment time and improving comfort.

Concealed cable management: Internal cable routing for easy and quick organization.

10cm adjustable design: Side zipper for easy adjustment to fit different weights.

Dedicated snap-lock airbags ensure precise treatment pressure delivery.

The foot can fold inward, allowing the airbags to precisely conform to the instep, sole, and ankle for comprehensive foot pressure therapy.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersExperienced Team

Guangzhou T&B Beauty Equipment Co., Ltd.

Guangdong, China

Business Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shenzhen Port, Guangzhou PortAverage Response Time: ≤2.89h

AI-Powered supplier vetting

SummaryThe supplier is identified as a Guangzhou-based trading company in the scientific research and technical services industry. It demonstrates broad customization, ODM, OEM, recent product development, inventory availability, CE certification, and 14 years of export experience, with exports representing 90% of total sales. Service infrastructure is limited: it has no overseas agents or branches, overseas warehouse, or showroom, and reports zero countries with overseas services. Lead times are stated as within 15 working days in both peak and off-season. Important controls remain unclear, including quality assurance, traceability, outsourcing procedures, contract status, and complaint-handling mechanisms. Financial information is present only as year labels, without usable performance details.

CertificationsCE certification is explicitly reported for product compliance with standards. The evidence confirms one certification but does not establish the scope, validity, or coverage of all products.

R&D capabilityThe supplier reports new products during the past year, provides ODM services, and has creative designers and engineers involved in product development. However, it has only one R&D engineer and no available SDK, so the evidence supports some innovation activity but not broad or advanced technical capability.

Customization capabilityBoth the general capability and R&D capability records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. The supplier also reports ODM availability, providing direct evidence of broad customization support.

Client casesThe supplier reports 14 years of export experience, 90% of sales from exports, OEM service for well-known brands, participation in Russia InterCHARM, and a repeat-buyer preference range of 50%–80%. It also states that its reputation was earned through product development, quality control, and customer satisfaction, but it explicitly reports no collaboration with Fortune 500 companies; the customer-case evidence is positive but limited in detail.